A detailed history of Orrstown Financial Services Inc transactions in Amgen Inc stock. As of the latest transaction made, Orrstown Financial Services Inc holds 1,538 shares of AMGN stock, worth $498,865. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,538
Previous 1,498 2.67%
Holding current value
$498,865
Previous $426 Million 12.83%
% of portfolio
0.25%
Previous 0.24%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$262.75 - $319.31 $10,510 - $12,772
40 Added 2.67%
1,538 $481 Million
Q4 2023

Jan 11, 2024

SELL
$255.7 - $288.46 $189,473 - $213,748
-741 Reduced 33.1%
1,498 $431 Million
Q1 2022

Apr 12, 2022

BUY
$219.27 - $242.57 $657 - $727
3 Added 0.13%
2,239 $541,000
Q4 2021

Jan 13, 2022

SELL
$198.88 - $227.6 $93,672 - $107,199
-471 Reduced 17.4%
2,236 $518,000
Q3 2021

Oct 01, 2021

SELL
$212.27 - $248.7 $4,457 - $5,222
-21 Reduced 0.77%
2,707 $576,000
Q2 2021

Jul 08, 2021

SELL
$233.58 - $259.14 $3,036 - $3,368
-13 Reduced 0.47%
2,728 $673,000
Q1 2021

Apr 07, 2021

BUY
$221.91 - $258.6 $6,213 - $7,240
28 Added 1.03%
2,741 $683,000
Q4 2020

Jan 13, 2021

BUY
$216.38 - $257.67 $18,392 - $21,901
85 Added 3.23%
2,713 $624,000
Q3 2020

Oct 06, 2020

SELL
$234.65 - $260.95 $24,168 - $26,877
-103 Reduced 3.77%
2,628 $671,000
Q2 2020

Jul 06, 2020

SELL
$197.81 - $242.74 $6,527 - $8,010
-33 Reduced 1.19%
2,731 $644,000
Q1 2020

Apr 02, 2020

BUY
$182.24 - $241.7 $146,885 - $194,810
806 Added 41.16%
2,764 $560,000
Q4 2019

Jan 17, 2020

BUY
$189.21 - $243.2 $350,227 - $450,163
1,851 Added 1729.91%
1,958 $473,000
Q3 2019

Oct 01, 2019

BUY
$174.11 - $208.62 $8,705 - $10,431
50 Added 87.72%
107 $22,000
Q2 2019

Jul 11, 2019

BUY
$166.7 - $195.41 $9,501 - $11,138
57 New
57 $11,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $174B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Orrstown Financial Services Inc Portfolio

Follow Orrstown Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orrstown Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Orrstown Financial Services Inc with notifications on news.